Source:http://linkedlifedata.com/resource/pubmed/id/21391788
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
2011-6-7
|
pubmed:abstractText |
Matrix metallaprotinase-9 (MMP-9) is zinc-containing proteinase whose expression and trafficking are frequently altered in cancer. MMP-9 in the plasma membrane and the secreted forms are thought to contribute to the invasive and metastatic properties of malignant tumors. We have manipulated the expression of MMP-9 in prostate tumor cell line LNCaP and measured their capacity to invade through a basement membrane matrix. Stable expression of human MMP-9 in a poorly metastatic LNCaP prostate cancer cell line produced a 2-3-fold increase in MMP-9 activity and a comparable increase in invasiveness. Transient transfection of LNCaP stable clone expressing MMP-9 with MMP-9 antisense oligonucleotide (ASODN) produced 55-90% less MMP-9 than control cells and were proportionately less invasive. In contrast, manipulating MMP-9 levels had no effect on cell migration across an uncoated membrane. A standard MMP-9 inhibitor at a concentration ranging from 1-10 nM, caused a nearly quantitative inhibition of extracellular MMP-9 activity and had significant effect on basement membrane invasion. Collectively, these results confirm the role of MMP-9 in tissue remodeling associated with prostate tumor invasion.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
1532-4311
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
40
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
447-64
|
pubmed:meshHeading |
pubmed-meshheading:21391788-Basement Membrane,
pubmed-meshheading:21391788-Cell Line, Tumor,
pubmed-meshheading:21391788-Enzyme Inhibitors,
pubmed-meshheading:21391788-Gene Expression,
pubmed-meshheading:21391788-Gene Expression Regulation, Neoplastic,
pubmed-meshheading:21391788-Gene Knockdown Techniques,
pubmed-meshheading:21391788-Humans,
pubmed-meshheading:21391788-Male,
pubmed-meshheading:21391788-Matrix Metalloproteinase 9,
pubmed-meshheading:21391788-Neoplasm Invasiveness,
pubmed-meshheading:21391788-Oligonucleotides, Antisense,
pubmed-meshheading:21391788-Prostatic Neoplasms
|
pubmed:year |
2011
|
pubmed:articleTitle |
Overexpression of MMP-9 contributes to invasiveness of prostate cancer cell line LNCaP.
|
pubmed:affiliation |
Department of Medicine, Division of Allergy, Immunology and Rheumatology, State University of New York at Buffalo and Buffalo General Hospital, Kaleida Health, New York 14203, USA. ra5@buffalo.edu
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|